BACKGROUND: Although evidence supports a relationship between human immunodeficiency virus (HIV)-1 exposure and HIV-1-specific CD8(+) T cell responses, studies have not demonstrated a direct association between the quantity of HIV-1 to which a person is exposed and the presence or absence of a response. METHODS: From 1999 to 2005, maternal HIV-1 RNA levels were measured in blood, cervical secretions, and breast milk at delivery and 1 month after delivery. HIV-1-specific interferon (IFN)-γ Elispot assays were conducted to determine infant CD8(+) T-cell responses at 3 months of age. RESULTS: Among 161 infants tested with Elispot assays, 23 (14%) had positive results. Mothers whose infants had a positive assay had higher breast milk HIV-1 RNA levels at month 1 compared with mothers whose infants had negative Elispot assays (3.1 vs 2.5 log(10) copies/mL; P = .017). Female infants were also more likely to have positive Elispot assays than male infants (P = .046), and in multivariate analyses, both female sex and high breast milk HIV-1 levels remained important predictors of a positive response (P = .022 and P = .015, respectively). CONCLUSIONS: Exposure to breast milk HIV-1 and sex were associated with development of HIV-1-specific CD8(+) T-cell responses in infants. These data support a role for mucosal exposure via the oral route in induction of systemic HIV-1-specific cellular immunity.
BACKGROUND: Although evidence supports a relationship between human immunodeficiency virus (HIV)-1 exposure and HIV-1-specific CD8(+) T cell responses, studies have not demonstrated a direct association between the quantity of HIV-1 to which a person is exposed and the presence or absence of a response. METHODS: From 1999 to 2005, maternal HIV-1 RNA levels were measured in blood, cervical secretions, and breast milk at delivery and 1 month after delivery. HIV-1-specific interferon (IFN)-γ Elispot assays were conducted to determine infantCD8(+) T-cell responses at 3 months of age. RESULTS: Among 161 infants tested with Elispot assays, 23 (14%) had positive results. Mothers whose infants had a positive assay had higher breast milk HIV-1 RNA levels at month 1 compared with mothers whose infants had negative Elispot assays (3.1 vs 2.5 log(10) copies/mL; P = .017). Female infants were also more likely to have positive Elispot assays than male infants (P = .046), and in multivariate analyses, both female sex and high breast milk HIV-1 levels remained important predictors of a positive response (P = .022 and P = .015, respectively). CONCLUSIONS: Exposure to breast milk HIV-1 and sex were associated with development of HIV-1-specific CD8(+) T-cell responses in infants. These data support a role for mucosal exposure via the oral route in induction of systemic HIV-1-specific cellular immunity.
Authors: R Kaul; S L Rowland-Jones; J Kimani; K Fowke; T Dong; P Kiama; J Rutherford; E Njagi; F Mwangi; T Rostron; J Onyango; J Oyugi; K S MacDonald; J J Bwayo; F A Plummer Journal: Immunol Lett Date: 2001-11-01 Impact factor: 3.685
Authors: Tara Beattie; Rupert Kaul; Tim Rostron; Tao Dong; Philippa Easterbrook; Walter Jaoko; Joshua Kimani; Francis Plummer; Andrew McMichael; Sarah Rowland-Jones Journal: AIDS Date: 2004-07-23 Impact factor: 4.177
Authors: J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann Journal: Science Date: 1999-02-05 Impact factor: 47.728
Authors: L Kuhn; A Coutsoudis; D Moodley; D Trabattoni; N Mngqundaniso; G M Shearer; M Clerici; H M Coovadia; Z Stein Journal: AIDS Date: 2001-01-05 Impact factor: 4.177
Authors: Emma L Turnbull; MaiLee Wong; Shuyi Wang; Xiping Wei; Nicola A Jones; Karen E Conrod; Diana Aldam; Jo Turner; Pierre Pellegrino; Brandon F Keele; Ian Williams; George M Shaw; Persephone Borrow Journal: J Immunol Date: 2009-06-01 Impact factor: 5.422
Authors: Brandon L Guthrie; Barbara Lohman-Payne; Amy Y Liu; Rose Bosire; Samuel Victor Nuvor; Robert Y Choi; Romel D Mackelprang; James N Kiarie; Stephen C De Rosa; Barbra A Richardson; Grace C John-Stewart; Carey Farquhar Journal: Clin Vaccine Immunol Date: 2012-09-12
Authors: A Y Liu; B Lohman-Payne; M H Chung; J Kiarie; J Kinuthia; J Slyker; B Richardson; D Lehman; C Farquhar; G John-Stewart Journal: Clin Exp Immunol Date: 2015-04-20 Impact factor: 4.330